You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

secukinumab

Showing 1 - 25 of 193
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Giant Cell Arteritis, Polymyalgia Rheumatica Trial (Secukinumab)

Not yet recruiting
  • Giant Cell Arteritis
  • Polymyalgia Rheumatica
  • Secukinumab
  • (no location specified)
Nov 8, 2023

Tolerability in Pediatric Patients With Psoriasis

Not yet recruiting
  • Moderate-to-severe Plaque Psoriasis
  • Secukinumab
  • (no location specified)
Nov 16, 2023

Vitiligo, Secukinumab Trial in Gent (Secukinumab)

Completed
  • Vitiligo
  • Secukinumab
  • Secukinumab
  • Gent, Oost-Vlaanderen, Belgium
    Department of Dermatology, Ghent University Hospital
Dec 22, 2022

Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)

Not yet recruiting
  • Polymyalgia Rheumatica
  • Secukinumab 300 mg
  • +2 more
  • (no location specified)
Mar 6, 2023

Collect inReal-world populatIon Data on Treatment Pattern of

Not yet recruiting
  • Hidradenitis Suppurativa
  • secukinumab
  • (no location specified)
Jun 26, 2023

Plaque Psoriasis Trial in Karachi (Secukinumab Injection)

Completed
  • Plaque Psoriasis
  • Secukinumab Injection
  • Karachi, Sindh, Pakistan
    Jinnah Post graduate Medical centre
Jun 4, 2023

Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

Not yet recruiting
  • Non-radiographic Axial Spondyloarthritis
  • Secukinumab
  • Placebo
  • (no location specified)
Nov 16, 2022

Patients Treated With Secukinumab for Moderate to Severe Plaque

Completed
  • Plaque Psoriasis
  • Secukinumab
  • Bangkok, Thailand
    Novartis Investigative Site
Dec 6, 2022

Rotator Cuff Tendinopathy Trial (Secukinumab, Placebo)

Not yet recruiting
  • Rotator Cuff Tendinopathy
  • Secukinumab
  • Placebo
  • (no location specified)
Feb 24, 2023

Rotator Cuff Tendinopathy Trial (Secukinumab, Placebo)

Not yet recruiting
  • Rotator Cuff Tendinopathy
  • Secukinumab
  • Placebo
  • (no location specified)
Feb 1, 2023

Hidradenitis Suppurativa (HS) Trial (secukinumab)

Available
  • Hidradenitis Suppurativa (HS)
  • secukinumab
  • (no location specified)
Oct 20, 2022

Psoriasis Trial in New York (Secukinumab, Placebo followed by Secukinumab)

Completed
Has Results
  • Psoriasis
  • Secukinumab
  • Placebo followed by Secukinumab
  • New York, New York
    The Rockefeller Univesity
Sep 26, 2022

Plaque Psoriasis Trial in Outram Park (secukinumab, Methotrexate, Cyclosporin A)

Not yet recruiting
  • Plaque Psoriasis
  • secukinumab
  • +3 more
  • Outram Park, Singapore
    Singapore General Hospital
Nov 23, 2022

Moderate-to-severe Plaque Psoriasis Patients Response to

Completed
  • Moderate-to-severe Plaque Psoriasis
    • Jakarta, Indonesia
      Mangga Besar Clinic
    Mar 15, 2023

    Secukinumab on Clinical and Patient Reported Outcomes in

    Completed
    • Psoriasis
    • Secukinumab
    • East Hanover, New Jersey
      Novartis Pharmaceuticals
    Aug 22, 2022

    Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)

    Recruiting
    • Giant Cell Arteritis
    • Secukinumab 300 mg, s.c.
    • Placebo to match Secukinumab, s.c.
    • Berlin, Germany
    • +2 more
    Oct 12, 2022

    Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

    Recruiting
    • Psoriasis Vulgaris
    • Venapuncture
    • Patient questionnaires
    • Ghent, East-Flanders, Belgium
    • +6 more
    Jan 16, 2023

    Secukinumab Effectiveness in Axial Spondyloarthritis and

    Completed
    • Axial Spondyloarthritis
    • Psoriatic Arthritis
    • secukinumab
    • Madrid, Spain
    • +2 more
    Dec 22, 2022

    Among Psoriasis Patients Treated With Cosentyx (Secukinumab)

    Completed
    • Psoriasis
    • Secukinumab
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 29, 2022

    Lupus Nephritis Trial (Secukinumab)

    Recruiting
    • Lupus Nephritis
    • Secukinumab
    • Westmead, New South Wales, Australia
    • +4 more
    Oct 19, 2022

    Tendinopathy Trial in Germany (secukinumab, Placebo)

    Recruiting
    • Tendinopathy
    • secukinumab
    • Placebo
    • Berlin, Germany
    • +7 more
    Jan 5, 2023

    Improvement and Quality of Life Trends for UK/ROI Patients

    Completed
    • Plaque Psoriasis
    • Secukinumab
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 29, 2022

    Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

    Completed
    • Plaque Psoriasis
    • Secukinumab
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 29, 2022

    Psoriasis Trial (BR201, Cosentyx(Secukinumab ))

    Not yet recruiting
    • Psoriasis
    • BR201
    • Cosentyx（Secukinumab ）
    • (no location specified)
    Nov 6, 2023

    Psoriasis Trial in New York (Secukinumab)

    Completed
    • Psoriasis
    • Secukinumab
    • New York, New York
      Mount Sinai West Dermatolgy
    Apr 8, 2022